Ag biotech comprises only 30% of DD’s sales, so DD offers much less exposure than MON and DE to the surefire ag growth being driven by The Global Demographic Tailwind.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”